Latest News

Thursday, February 26, 2015 | FDA Approval/Clearance

Lupin Receives FDA Approval for Generic Lumigan Ophthalmic Solution 0.03%

Pharma Major Lupin Limited (Lupin) announced that it has received final approval for its bimatoprost ophthalmic solution, 0.03% from the FDA to market a generic version of Allergan's Lumigan Ophth…

Read the full story

Thursday, February 26, 2015 | Product Releases, Carl Zeiss Meditec

Zeiss Launches Humphrey Field Analyzer 3 Visual Field Testing System

At the American Glaucoma Society 2015 annual meeting in Coronado, California, Zeiss is announcing the global launch of the Humphrey Field Analyzer 3 (HFA3), the next generation in visual field t…

Read the full story

Thursday, February 26, 2015 | Miscellaneous

Envision Receives $300K Mabee Challenge Grant for Research Institute

Envision announced that it has received a $300,000 challenge grant from the Tulsa, Okla.-based J.E. and L.E. Mabee Foundation, which will support renovation of an entire floor of Envision’s Wich…

Read the full story

Thursday, February 26, 2015 | Glaucoma

XEN Gel Stent Receives Approval from Health Canada to Treat Glaucoma

AqueSys, the developer of minimally invasive stent technology for the treatment of glaucoma, announced that the company received a Class 3 Medical Device License for the XEN Gel Stent from Health Cana…

Read the full story

Thursday, February 26, 2015 | Medical Studies

New Diagnostic Test Proposed for Myasthenia Gravis

Ocular vestibular-evoked myogenic potentials could be the basis of a new test for myasthenia gravis, according to the results of a recent study. "We're very excited because it's a simple …

Read the full story

Thursday, February 26, 2015 | Medical Studies

New Pathways Discovered to Prevent Blindness

Scientists have made a major new discovery detailing how areas of the brain responsible for vision could potentially adapt to injury or trauma and ultimately prevent blindness. The Monash University l…

Read the full story

Thursday, February 26, 2015 | Medical Studies

Telescopic Contact Lens Shows Promise for AMD

An innovation that combines a telescopic contact lens with "smart" glasses that look like normal eyewear looks set to be a great help to people with serious vision problems, such as age-rela…

Read the full story

Wednesday, February 25, 2015 | Avedro

FDA Advisory Panel Recommends Approval of Avedro’s Cross-Linking Platform

A joint FDA advisory panel on Tuesday recommended approval of Avedro’s combined riboflavin ophthalmic solutions and ultraviolet light irradiation for corneal collagen cross-linking. The recommen…

Read the full story

Wednesday, February 25, 2015 | Medical Studies

Pupil Contraction Test Detects Neuropathy in a Single Eye

Transient pupil contractions in response to bright blue light can objectively reveal optic neuropathy in one eye, independent of its fellow eye, researchers say. "This could be a clinical tool fo…

Read the full story

Wednesday, February 25, 2015 | Miscellaneous, Heidelberg Engineering

NASA Presents Heidelberg Engineering the NASA Certificate of Appreciation

Heidelberg Engineering received the NASA Certificate of Appreciation in recognition of Heidelberg Engineering’s support in placing a Spectralis OCT system on the International Space Station…

Read the full story

Tuesday, February 24, 2015 | Product Releases, Second Sight Medical Products

Second Sight Announces First Commercial Implants of the Argus II Retinal Prosthesis System in France

Second Sight Medical Products announced that all three of the centers approved to implant the Argus II Retinal Prosthesis System under the French Government national healthcare reimbursement program e…

Read the full story

Tuesday, February 24, 2015 | Medical Studies

Europe Approves Western World's First Stem-Cell Therapy for Rare Eye Condition

Europe has approved the Western world's first medicine containing stem cells to treat a rare condition caused by burns to the eye, marking a milestone in the use of the technology. Holoclar, from …

Read the full story

Tuesday, February 24, 2015 | Acquisitions/Mergers

Billionaire John Paulson Backs Valeant's Takeover Of Salix Pharmaceuticals Amid Consolidation Bet

Paulson & Co. is supportive of Valeant Pharmaceuticals $158 a share takeover of Salix Pharmaceuticals, after the merger focused hedge fund added to its bets on the consolidation of the pharma…

Read the full story

Tuesday, February 24, 2015 | Medical Studies

With Generic Drugs, Eye Patients Are More Likely to Take Medicine as Directed

When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug…

Read the full story

Monday, February 23, 2015 | Product Releases, IRIDEX

Iridex To Debut Cyclo G6 Glaucoma Laser Platform and Present New Clinical Data at the American Glaucoma Society's Annual Meeting

Iridex announced that it will debut the Cyclo G6, the company’s first laser platform dedicated to the treatment of glaucoma, at this year’s annual congress of the American Glaucoma Society…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $28.61  2.07% 
 Akorn, Inc. $53.47  15.24% 
 Alimera Sciences, Inc. $5.28  -0.38% 
 Allergan, Inc. $232.40  -0.03% 
 Avalanche $36.75  -0.57% 
 Bayer $147.35  2.00% 
 Can-Fite Biopharma $4.67  10.66% 
 Carl Zeiss Meditec $24.55  -0.67% 
 Cooper Companies, Inc. $165.45  1.22% 
 Escalon Medical Corp. $1.45  4.62% 
 Essilor International $115.00  0.00% 
 Imprimis Pharmaceuticals, Inc. $7.77  1.46% 
 InSite Vision, Inc. $0.21  2.50% 
 IRIDEX Corporation $10.72  -0.60% 
 Johnson & Johnson $102.80  1.57% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $61.66  -0.50% 
 Merck & Company, Inc. $58.96  0.80% 
 NicOx $2.10  1.35% 
 NovaBay Pharmaceuticals, Inc. $0.52  -5.45% 
 Novartis AG Common Stock $103.00  0.35% 
 Ocular Therapeutix $35.06  4.25% 
 Ophthotech Corporation $54.80  -0.40% 
 Quantel $3.53  2.92% 
 Regeneron $419.87  -0.75% 
 Roche $33.86  -0.12% 
 STAAR Surgical Company $7.93  9.08% 
 TearLab Corporation $2.68  1.13% 
 Thrombogenics $8.48  0.00% 
 Topcon Corporation $19.85  0.00% 
 Valeant Pharmaceuticals $201.25  1.64% 
 Xoma $3.83  -4.01%